243 related articles for article (PubMed ID: 36549780)
21. Terminal differentiation of bone marrow NK cells and increased circulation of TIGIT
Zeng X; Yao D; Liu L; Zhang Y; Lai J; Zhong J; Zha X; Lu Y; Jin Z; Chen S; Li Y; Xu L
Asia Pac J Clin Oncol; 2022 Aug; 18(4):456-464. PubMed ID: 34811925
[TBL] [Abstract][Full Text] [Related]
22. Lactate acid promotes PD-1
Zhang Y; Huang Y; Hong Y; Lin Z; Zha J; Zhu Y; Li Z; Wang C; Fang Z; Zhou Z; Peng Y; Yu X; Liu L; Xu B
Int Immunopharmacol; 2024 Mar; 130():111765. PubMed ID: 38447414
[TBL] [Abstract][Full Text] [Related]
23. Monitoring TIGIT/DNAM-1 and PVR/PVRL2 Immune Checkpoint Expression Levels in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia.
Hattori N; Kawaguchi Y; Sasaki Y; Shimada S; Murai S; Abe M; Baba Y; Watanuki M; Fujiwara S; Arai N; Kabasawa N; Tsukamoto H; Uto Y; Yanagisawa K; Saito B; Harada H; Nakamaki T
Biol Blood Marrow Transplant; 2019 May; 25(5):861-867. PubMed ID: 30639819
[TBL] [Abstract][Full Text] [Related]
24. Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment.
Sakakura K; Takahashi H; Kaira K; Toyoda M; Murata T; Ohnishi H; Oyama T; Chikamatsu K
Lab Invest; 2016 Sep; 96(9):994-1003. PubMed ID: 27322955
[TBL] [Abstract][Full Text] [Related]
25. High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis.
Li P; Yuan J; Ahmed FS; McHenry A; Fu K; Yu G; Cheng H; Xu ML; Rimm DL; Pan Z
Front Oncol; 2021; 11():701492. PubMed ID: 34527580
[TBL] [Abstract][Full Text] [Related]
26. Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option.
Stamm H; Klingler F; Grossjohann EM; Muschhammer J; Vettorazzi E; Heuser M; Mock U; Thol F; Vohwinkel G; Latuske E; Bokemeyer C; Kischel R; Dos Santos C; Stienen S; Friedrich M; Lutteropp M; Nagorsen D; Wellbrock J; Fiedler W
Oncogene; 2018 Sep; 37(39):5269-5280. PubMed ID: 29855615
[TBL] [Abstract][Full Text] [Related]
27. Tim-3 facilitates immune escape in benzene-induced acute myeloid leukemia mouse model by promoting macrophage M2 polarization.
Ning Q; Jian T; Cui S; Shi L; Jian X; He X; Zhang X; Li X
Ecotoxicol Environ Saf; 2023 Nov; 266():115532. PubMed ID: 37806131
[TBL] [Abstract][Full Text] [Related]
28. Polarization of Human Monocyte-Derived Cells With Vitamin D Promotes Control of
Rao Muvva J; Parasa VR; Lerm M; Svensson M; Brighenti S
Front Immunol; 2019; 10():3157. PubMed ID: 32038652
[No Abstract] [Full Text] [Related]
29. Characteristic of TIGIT and DNAM-1 Expression on Foxp3+
Jin Z; Ye W; Lan T; Zhao Y; Liu X; Chen J; Lai J; Chen S; Zhong X; Wu X
Biomed Res Int; 2020; 2020():4612952. PubMed ID: 32802845
[TBL] [Abstract][Full Text] [Related]
30. Loss of CD28 expression associates with severe T-cell exhaustion in acute myeloid leukemia.
Huang Y; Zheng H; Zhu Y; Hong Y; Zha J; Lin Z; Li Z; Wang C; Fang Z; Yu X; Liu L; Xu B
Front Immunol; 2023; 14():1139517. PubMed ID: 36960073
[TBL] [Abstract][Full Text] [Related]
31. CTLA4-Ig treatment induces M1-M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients.
Cutolo M; Soldano S; Gotelli E; Montagna P; Campitiello R; Paolino S; Pizzorni C; Sulli A; Smith V; Tardito S
Arthritis Res Ther; 2021 Dec; 23(1):306. PubMed ID: 34952630
[TBL] [Abstract][Full Text] [Related]
32. The M2 macrophage marker
Xu ZJ; Gu Y; Wang CZ; Jin Y; Wen XM; Ma JC; Tang LJ; Mao ZW; Qian J; Lin J
Oncoimmunology; 2020; 9(1):1683347. PubMed ID: 32002295
[TBL] [Abstract][Full Text] [Related]
33. Hepatic leukemia-associated macrophages exhibit a pro-inflammatory phenotype in Notch1-induced acute T cell leukemia.
Yang X; Feng W; Wang R; Yang F; Wang L; Chen S; Chen C; Ren Q; Zheng G
Immunobiology; 2018 Jan; 223(1):73-80. PubMed ID: 29030004
[TBL] [Abstract][Full Text] [Related]
34. Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation.
You X; Liu F; Binder M; Vedder A; Lasho T; Wen Z; Gao X; Flietner E; Rajagopalan A; Zhou Y; Finke C; Mangaonkar A; Liao R; Kong G; Ranheim EA; Droin N; Hunter AM; Nikolaev S; Balasis M; Abdel-Wahab O; Levine RL; Will B; Nadiminti KVG; Yang D; Geissler K; Solary E; Xu W; Padron E; Patnaik MM; Zhang J
Blood; 2022 Feb; 139(7):1066-1079. PubMed ID: 34699595
[TBL] [Abstract][Full Text] [Related]
35. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
[TBL] [Abstract][Full Text] [Related]
36. Tim-3 signaling blockade with α-lactose induces compensatory TIGIT expression in Plasmodium berghei ANKA-infected mice.
Zhang Y; Jiang N; Zhang T; Chen R; Feng Y; Sang X; Yang N; Chen Q
Parasit Vectors; 2019 Nov; 12(1):534. PubMed ID: 31711531
[TBL] [Abstract][Full Text] [Related]
37. Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages.
Abumaree MH; Al Jumah MA; Kalionis B; Jawdat D; Al Khaldi A; Abomaray FM; Fatani AS; Chamley LW; Knawy BA
Stem Cell Rev Rep; 2013 Oct; 9(5):620-41. PubMed ID: 23812784
[TBL] [Abstract][Full Text] [Related]
38. Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation.
Han JH; Cai M; Grein J; Perera S; Wang H; Bigler M; Ueda R; Rosahl TW; Pinheiro E; LaFace D; Seghezzi W; Williams SMG
Front Immunol; 2020; 11():573405. PubMed ID: 33117369
[TBL] [Abstract][Full Text] [Related]
39. PD-1 and TIGIT Are Highly Co-Expressed on CD8
Xu L; Liu L; Yao D; Zeng X; Zhang Y; Lai J; Zhong J; Zha X; Zheng R; Lu Y; Li M; Jin Z; Hebbar Subramanyam S; Chen S; Huang X; Li Y
Front Oncol; 2021; 11():686156. PubMed ID: 34490086
[TBL] [Abstract][Full Text] [Related]
40. Exosomes derived from rapamycin-treated 4T1 breast cancer cells induced polarization of macrophages to M1 phenotype.
Ghalavand M; Moradi-Chaleshtori M; Dorostkar R; Mohammadi-Yeganeh S; Hashemi SM
Biotechnol Appl Biochem; 2023 Oct; 70(5):1754-1771. PubMed ID: 37254633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
